| __timestamp | Galapagos NV | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9079000 | 20140000 |
| Thursday, January 1, 2015 | 20309000 | 37173000 |
| Friday, January 1, 2016 | 16945000 | 48616000 |
| Sunday, January 1, 2017 | 20559000 | 108488000 |
| Monday, January 1, 2018 | 29641000 | 244622000 |
| Tuesday, January 1, 2019 | 88258000 | 287000000 |
| Wednesday, January 1, 2020 | 162170000 | 354000000 |
| Friday, January 1, 2021 | 167218000 | 186000000 |
| Saturday, January 1, 2022 | 239528000 | 151000000 |
| Sunday, January 1, 2023 | 94252000 | 232600000 |
| Monday, January 1, 2024 | 267474000 |
Cracking the code
In the competitive landscape of biotechnology, effective cost management is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Ionis Pharmaceuticals, Inc. and Galapagos NV from 2014 to 2023. Over this period, Ionis Pharmaceuticals consistently outpaced Galapagos NV in SG&A spending, peaking in 2020 with expenses nearly 120% higher than Galapagos NV. However, by 2022, Galapagos NV's SG&A expenses surged, reaching 159% of their 2014 levels, indicating a strategic shift in their operational focus. Meanwhile, Ionis Pharmaceuticals saw a reduction in SG&A expenses by 2022, reflecting a potential optimization in their cost structure. This trend highlights the dynamic nature of financial strategies within the biotech sector, where companies must balance operational costs with the pursuit of groundbreaking therapies.
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Galapagos NV Trends and Insights
Cost Management Insights: SG&A Expenses for Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc.
Bio-Techne Corporation vs Galapagos NV: SG&A Expense Trends
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
Ionis Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
Who Optimizes SG&A Costs Better? Merus N.V. or Galapagos NV
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights